Hsiao D. Lieu

Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial

Ami E. Iskandrian, Timothy M. Bateman, Luiz Belardinelli et al. · Journal of Nuclear Cardiology · 2007 · 345 citations

Medicine, Cardiology, Radiology +17

Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis

Stephen A. Harrison, Guy Neff, Cynthia D. Guy et al. · Gastroenterology · 2020 · 265 citations · Full text

Medicine, Pharmacotherapy, Hepatology +16

Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

Hsiao D. Lieu, John C. Shryock, Gregory O. von Mering et al. · Journal of Nuclear Cardiology · 2007 · 139 citations

Medicine, Cardiology, Pharmacology +11

Eliminating Atherogenesis in Mice by Switching Off Hepatic Lipoprotein Secretion

Hsiao D. Lieu, Shannon K. Withycombe, Quinn M. Walker et al. · Circulation · 2003 · 118 citations

Life Sciences, Genetics, Molecular Genetics +17

Pharmacodynamics Pharmacodynamics of a Novel Designer Natriuretic Peptide, CD‐NP, in a First‐in‐Human Clinical Trial in Healthy Subjects

Candace Y.W. Lee, Horng H. Chen, Ondřej Lisý et al. · The Journal of Clinical Pharmacology · 2009 · 109 citations · Full text

Medicine, Cardiology, Pharmacology +16